Sort by AttachmentsUse SHIFT+ENTER to open the menu (new window).
DetailsFilter
  
1) Pharmacogenomics of (CYP3A4, CYP3A5, CYP2C19, CYP2C9, CYP2D6, VKORC1, and MDR-1) in relation to pharmacokinetics and pharmacodynamics of tacrolimus, cyclosporine, clopidogrel and warfarin 2) Cancer pharmacogenomics (Lung cancer, colorectal cancer and breast cancer in relation with methyleneterahydrofolate, thymidylate synthase, and other genes involved in folate pathway) 3) Pharmacogenetic differences of different ethnicities in Jordan 4) Pharmacogenomics and susceptibility to diseases 5) Pharmacogenomics and adverse effects of medicaments
  
Development of pharmaceutical care in Jordan Development of pharmaceutical care education Rational Use of Drugs Self medication among Jordanians Misuse and abuse in community pharmacy Management gaps in the treatment of chronic diseases (HTN, DM, dyslipidemia and others) Pharmacokinetics and population pharmacokinetics of antiplatelets (clopidogrel and ticagrelor) Factors that influence response to antiplatelet agents